Preventing tumors shedding their identifying proteins allows immune system to attack
Histological
analysis (Fontana-Masson staining) of lung tissue demonstrated an
apparent reduction in the number and size of metastases in mice that
were treated with the MICA antibody (representative of five mice).
A team of researchers have found that introducing an antibody into a cancerous mouse model prevented the escape of ligands from a tumor surface allowing natural killer cells to attack. In their paper published, the group describes their technique and how well it worked. A researcher offers an overview of the work done by the team in a Perspective piece in the same journal issue and also gives an overview of immunotherapy research in general.
Prior research has shown that one of the reasons the immune system
has trouble recognizing tumors as a threat is the their tendency to shed
proteins that the immune system uses to identify them. In this new
effort, the researchers focused on MICA and MICB, proteins that are
produced by tumors and wind up on their exposed surfaces, which the
immune system would normally be able to identify. But before that can
happen, the tumor actually produces an enzyme that separates the
proteins from the tumor surface—essentially shedding them and preventing
the immune system from using them as a signal to go on the offensive.
In this new effort, the researchers looked into whether there might be a
way to prevent tumors from shedding such proteins, thereby allowing the
immune system to do its work.
After some searching, the team settled on an antibody called mAb
7C6—they found that when applied to mouse models with lung cancer and
melanoma, the antibody caused levels of both MICA and MICB to increase
on tumor surfaces, suggesting that the tumor had been unsuccessful in
shedding them. Furthermore, they also found that killer immune cells
were then alerted to the tumor and attacked it, which, the researchers
report, resulted in a reduced tumor load.
The technique,the author notes, is one of many that are being developed to help the immune system fight tumors, rather than attacking tumors directly via medical interventions. Such therapies, it is believed, will have fewer undesirable side-effects.
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES. PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG- https://gseasyrecipes.blogspot.com/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG- https:// kneereplacement-stickclub.blogspot.com/
FOR CROCHET DESIGNS https://my crochet creations.blogspot.com/
A team of researchers have found that introducing an antibody into a cancerous mouse model prevented the escape of ligands from a tumor surface allowing natural killer cells to attack. In their paper published, the group describes their technique and how well it worked. A researcher offers an overview of the work done by the team in a Perspective piece in the same journal issue and also gives an overview of immunotherapy research in general.
The technique,the author notes, is one of many that are being developed to help the immune system fight tumors, rather than attacking tumors directly via medical interventions. Such therapies, it is believed, will have fewer undesirable side-effects.
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES. PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG- https://gseasyrecipes.blogspot.com/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG- https:// kneereplacement-stickclub.blogspot.com/
FOR CROCHET DESIGNS https://my crochet creations.blogspot.com/
Labels: antibody- mAb76, immune system, ligands, lung cancer, Melanoma, MICA & MICB proteins, tumour
0 Comments:
Post a Comment
<< Home